Shortage of plasma-derived products: a looming crisis?

被引：21
|
作者：
Li Covington, Mischa [1 ]
Voma, Chesinta [2 ]
Stowell, Sean R. [1 ,2 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Joint Program Transfus Med, Dept Pathol, 630E New Res Bldg, Boston, MA 02115 USA
[2] Qualtex Labs, Norcross, GA USA
来源：
BLOOD | 2022年 / 139卷 / 21期
关键词：
RANDOMIZED-TRIAL; FACTOR-VIII; BLOOD; FREQUENCY;
D O I：
10.1182/blood.2021015370
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3222 / 3225
页数：4
相关论文
共 50 条
  • [21] FDA to propose tracking, notification system for plasma-derived products
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (22) : 2274 - 2274
  • [22] Factor VIII safety: plasma-derived versus recombinant products
    Gringeri, Alessandro
    BLOOD TRANSFUSION, 2011, 9 (04) : 366 - 370
  • [23] Cellular Stress Induced by Plasma-Derived Factor VIII Products
    Brodde, Martin
    Mueller, Anja
    Kehrel, Beate
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2014, 41 (02) : 140 - 144
  • [24] Public expenditure for plasma-derived and recombinant medicinal products in Italy
    Lanzoni, Monica
    Candura, Fabio
    Calizzani, Gabriele
    Biffoli, Claudia
    Grazzini, Giuliano
    BLOOD TRANSFUSION, 2013, 11 : S110 - S117
  • [25] Immune Responses to Plasma-Derived Versus Recombinant FVIII Products
    Peyvandi, Flora
    Miri, Syna
    Garagiola, Isabella
    FRONTIERS IN IMMUNOLOGY, 2021, 11
  • [26] Inactivation of emerging viruses by pasteurization in plasma-derived medicinal products
    Roth, N. J.
    Schaefer, W.
    Nowak, T.
    Popp, B.
    Schlosser, J.
    Eiden, M.
    Groschup, M.
    Groener, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 970 - 971
  • [27] Plasma-derived medicinal products in Italy: information sources and flows
    Lanzoni, Monica
    Biffoli, Claudia
    Candura, Fabio
    Calizzani, Gabriele
    Vaglio, Stefania
    Grazzini, Giuliano
    BLOOD TRANSFUSION, 2013, 11 : S13 - S17
  • [28] Quantifying the thrombogenic potential of human plasma-derived immunoglobulin products
    Germishuizen, W. A.
    Gyure, D. C.
    Stubbings, D.
    Burnouf, T.
    BIOLOGICALS, 2014, 42 (05) : 260 - 270
  • [29] Why do clinicians use plasma-derived blood products?
    Tasaki, T
    Gotoh, K
    Itoh, C
    Komai, M
    Nagasawa, Y
    Oikawa, S
    Takahashi, K
    TRANSFUSION, 1999, 39 (10) : 25S - 25S
  • [30] Clinical outcomes from the evolution in quality of plasma-derived products
    Dash, C.
    VOX SANGUINIS, 2006, 91 : 19 - 19
12345